Sulbactam-durlobactam for infections caused by Acinetobacter baumannii-calcoaceticus complex - Authors' reply. 2023

Keith S Kaye, and Sarah M McLeod, and John P O'Donnell, and David Altarac
Division of Allergy, Immunology and Infectious Diseases, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ 08901, USA. Electronic address: kk1116@rwjms.rutgers.edu.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013407 Sulbactam A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone. Bétamaze,CP-45899,Combactam,Penicillanic Acid Sulfone,Sulbactam Sodium,CP 45899,CP45899,Sodium, Sulbactam,Sulfone, Penicillanic Acid
D016954 Acinetobacter calcoaceticus A species of gram-negative, aerobic bacteria found in soil and water. Although considered to be normally nonpathogenic, this bacterium is a causative agent of nosocomial infections, particularly in debilitated individuals. Micrococcus calcoaceticus,Moraxella calcoacetica,Neisseria winogradskyi
D040981 Acinetobacter baumannii A species of gram-negative, aerobic bacteria, commonly found in the clinical laboratory, and frequently resistant to common antibiotics. Bacterium anitratum

Related Publications

Keith S Kaye, and Sarah M McLeod, and John P O'Donnell, and David Altarac
August 2023, The Lancet. Infectious diseases,
Keith S Kaye, and Sarah M McLeod, and John P O'Donnell, and David Altarac
June 2015, Infectious diseases (London, England),
Keith S Kaye, and Sarah M McLeod, and John P O'Donnell, and David Altarac
July 2024, The Annals of pharmacotherapy,
Keith S Kaye, and Sarah M McLeod, and John P O'Donnell, and David Altarac
March 2020, Antimicrobial agents and chemotherapy,
Keith S Kaye, and Sarah M McLeod, and John P O'Donnell, and David Altarac
July 2024, Diagnostic microbiology and infectious disease,
Keith S Kaye, and Sarah M McLeod, and John P O'Donnell, and David Altarac
September 2012, Journal of clinical microbiology,
Keith S Kaye, and Sarah M McLeod, and John P O'Donnell, and David Altarac
September 2022, Antimicrobial agents and chemotherapy,
Keith S Kaye, and Sarah M McLeod, and John P O'Donnell, and David Altarac
January 2024, Antimicrobial agents and chemotherapy,
Keith S Kaye, and Sarah M McLeod, and John P O'Donnell, and David Altarac
December 2022, Antibiotics (Basel, Switzerland),
Keith S Kaye, and Sarah M McLeod, and John P O'Donnell, and David Altarac
December 2023, Antibiotics (Basel, Switzerland),
Copied contents to your clipboard!